YFRM Technologies, Inc. Completes Acquisition of the Integrative Stem Cell Institute

PITTSTON, ME — (Marketwired) — 05/21/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm) is pleased to announce the completion of its acquisition of the Integrative Stem Cell Institute (the ISCI). The new company, to be called "the Integrative Stem Cell Institute," will continue the pioneering work of the ISCI in the field of cell-based regenerative medicine. The ISCI will be housed in Cancun-s Hospital Galenia and will combine a world-class medical facility with a state-of-

YaFarm Technologies, Inc. Announces ISCI Grand Opening

PITTSTON, ME — (Marketwire) — 03/27/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce the grand opening of The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies. The Institute is located within Hospital Galenia at 77505 Benito Juárez Quintana Roo, Mexico and the telephone number is 1.503.446.5039 (US).The grand opening event, scheduled for 6:30PM on Thursday, April 25, 2013 will introd

YaFarm Technologies Announces ISCI Release of Patient Publications

PITTSTON, ME — (Marketwire) — 03/04/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce the Integrative Stem Cell Institute (ISCI) has released three proprietary documents for patients seeking stem cell based therapies. These documents concerning stem cell procedures will be available to both new and existing patients.The three articles that the ISCI has published are:The ISCI Vetting Stem Cell Clinics provides a clear and concise overview of are

YaFarm Technologies Announces ISCI Clinical Study

PITTSTON, ME — (Marketwire) — 02/25/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has initiated its first clinical study in Degenerative Neuromuscular Diseases (DNMD).The clinical studies will be conducted at the ISCI facility in the Hospital Galenia in Cancun, Mexico and will consist of an integrative approach that will combine autolog

ISCI Announces Medical & Laboratory Director

PITTSTON, ME — (Marketwire) — 02/21/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has announced the appointment of Dr Eduardo Cervera Ceballos, MD as its Medical and Laboratory Director.Dr Cervera, a licensed hematologist, is currently a Director at the National Cancer Institute in Mexico City. He is a graduate of the Autonomous Univers

YaFarm Technologies, Inc. Recaps Major Developments

PITTSTON, ME — (Marketwire) — 02/19/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) has reached several important milestones since signing the definitive agreement with The Integrative Stem Cell Institute (ISCI). YaFarm has appointed top level management for ISCI by announcing David Audley as CEO and Juan A. Castillo as Chairman of the Board of Directors. Dr. Castillo is a pioneer in regenerative medicine and has successfully treated over 250 patients using adult s

YaFarm Technologies Announces ISCI IRB Submission

PITTSTON, ME — (Marketwire) — 02/15/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has submitted its complete protocols for the treatment of chronic and degenerative diseases to the Institutional Review Board (IRB) of the International Cell Surgical Society (ICSS).ISCI submitted the protocols for independent evaluation and review